HomeClinical TopicsEarly, intensive therapy for type 2 diabetes can slow progression

Early, intensive therapy for type 2 diabetes can slow progression

Author(s):

A study of 58 patients with type 2 diabetes found that early and intensive therapy helped preserve beta cell function for 3.5 years. In the study, published in Diabetes Care, patients with newly diagnosed type 2 diabetes received insulin and metformin for 3 months, then were randomly assigned to one of two groups: 1) insulin plus metformin and 2) triple oral therapy (metformin, glyburide, and pioglitazone). Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content

For Nurse Practitioners

covid-19 virus illustration

Will Omicron Be More Contagious Than Delta?

If the first thing you heard about the omicron variant over the holiday weekend was that it is bad news, the second thing was...